Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer
Public ClinicalTrials.gov record NCT03049358. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Olfactory Training For Post Radiation Olfactory Loss In Patients With Paranasal Sinus and Nasopharyngeal Carcinoma
Study identification
- NCT ID
- NCT03049358
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Stanford University
- Other
- Enrollment
- 15 participants
Conditions and interventions
Conditions
- Stage 0 Nasopharyngeal Carcinoma
- Stage 0 Paranasal Sinus Cancer
- Stage I Nasopharyngeal Carcinoma
- Stage I Paranasal Sinus Cancer
- Stage II Nasopharyngeal Carcinoma
- Stage II Paranasal Sinus Cancer
- Stage IIA Nasopharyngeal Carcinoma
- Stage IIB Nasopharyngeal Carcinoma
- Stage III Nasopharyngeal Carcinoma
- Stage III Paranasal Sinus Cancer
- Stage IV Nasopharyngeal Carcinoma
- Stage IV Paranasal Sinus Cancer
- Stage IVA Nasopharyngeal Carcinoma
- Stage IVA Paranasal Sinus Cancer
- Stage IVB Nasopharyngeal Carcinoma
- Stage IVB Paranasal Sinus Cancer
- Stage IVC Nasopharyngeal Carcinoma
- Stage IVC Paranasal Sinus Cancer
Interventions
- Physiologic Testing Other
- Quality-of-Life Assessment Other
- Sham Intervention Procedure
- Therapeutic Procedure Procedure
- canola oil placebo Other
- clove essential oil Other
- eucalyptus essential oil Other
- lemon essential oil Other
- rose essential oil Other
Other · Procedure
Eligibility (public fields only)
- Age range
- 19 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2016
- Primary completion
- Sep 30, 2018
- Completion
- Sep 30, 2018
- Last update posted
- Feb 4, 2019
2016 – 2018
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford University, School of Medicine | Palo Alto | California | 94304 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03049358, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 4, 2019 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03049358 live on ClinicalTrials.gov.